Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan
- PMID: 24602937
- DOI: 10.1086/675611
Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan
Abstract
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are clinically challenging, threaten patient safety, and represent an emerging public health issue. CRE reporting is not mandated in Michigan.
Methods: The Michigan Department of Community Health-led CRE Surveillance and Prevention Initiative enrolled 21 facilities (17 acute care and 4 long-term acute care facilities) across the state. Baseline data collection began September 1, 2012, and ended February 28, 2013 (duration, 6 months). Enrolled facilities voluntarily reported cases of Klebsiella pneumoniae and Escherichia coli according to the surveillance algorithm. Patient demographic characteristics, laboratory testing, microbiology, clinical, and antimicrobial information were captured via standardized data collection forms. Facilities reported admissions and patient-days each month.
Results: One-hundred two cases over 957,220 patient-days were reported, resulting in a crude incidence rate of 1.07 cases per 10,000 patient-days. Eighty-nine case patients had test results positive for K. pneumoniae, whereas 13 had results positive for E. coli. CRE case patients had a mean age of 63 years, and 51% were male. Urine cultures (61%) were the most frequently reported specimen source. Thirty-five percent of cases were hospital onset; sixty-five percent were community onset (CO), although 75% of CO case patients reported healthcare exposure within the previous 90 days. Cardiovascular disease, renal failure, and diabetes mellitus were the most frequently reported comorbid conditions. Common ris k factors included surgery within the previous 90 days, recent infection or colonization with a multidrug-resistant organism, and recent exposures to antimicrobials, especially third- or fourth-generation cephalosporins.
Conclusions: CRE are found throughout Michigan healthcare facilities. Implementing a regional, coordinated surveillance and prevention initiative may prevent CRE from becoming hyperendemic in Michigan.
Similar articles
-
Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.Infect Control Hosp Epidemiol. 2014 Apr;35(4):398-405. doi: 10.1086/675614. Infect Control Hosp Epidemiol. 2014. PMID: 24602945
-
Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.Infect Control Hosp Epidemiol. 2014 Apr;35(4):356-61. doi: 10.1086/675605. Infect Control Hosp Epidemiol. 2014. PMID: 24602939
-
Development and Distribution of Educational Materials for Carbapenem-Resistant Enterobacteriaceae Among Acute and Long-term Care Facilities.WMJ. 2015 Apr;114(2):48-51. WMJ. 2015. PMID: 26756056
-
An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.Clin Infect Dis. 2014 Mar;58(5):697-703. doi: 10.1093/cid/cit795. Epub 2013 Dec 4. Clin Infect Dis. 2014. PMID: 24304707 Review.
-
Carbapenem-resistant enterobacteriaceae: an emerging problem in children.Clin Infect Dis. 2012 Sep;55(6):852-9. doi: 10.1093/cid/cis543. Epub 2012 Jun 14. Clin Infect Dis. 2012. PMID: 22700827 Review.
Cited by
-
Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016-2022.Emerg Infect Dis. 2023 Oct;29(10):1973-1978. doi: 10.3201/eid2910.230153. Emerg Infect Dis. 2023. PMID: 37735742 Free PMC article. Review.
-
Whole-genome sequencing analysis of Klebsiella aerogenes among men who have sex with men in Guangzhou, China.Front Microbiol. 2023 Jun 2;14:1102907. doi: 10.3389/fmicb.2023.1102907. eCollection 2023. Front Microbiol. 2023. PMID: 37333657 Free PMC article.
-
Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.Antimicrob Resist Infect Control. 2022 Dec 19;11(1):161. doi: 10.1186/s13756-022-01204-w. Antimicrob Resist Infect Control. 2022. PMID: 36536423 Free PMC article.
-
Urinary Catheters Coated with a Novel Biofilm Preventative Agent Inhibit Biofilm Development by Diverse Bacterial Uropathogens.Antibiotics (Basel). 2022 Oct 30;11(11):1514. doi: 10.3390/antibiotics11111514. Antibiotics (Basel). 2022. PMID: 36358169 Free PMC article.
-
Characteristics of community-acquired carbapenem-resistant Enterobacterales.J Antimicrob Chemother. 2022 Sep 30;77(10):2763-2771. doi: 10.1093/jac/dkac239. J Antimicrob Chemother. 2022. PMID: 36179278 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical